MARATTO

article · BPB Reports

Analysis of OSW-1-Induced Stress Responses in HT-29 Cells

Abstract

OSW-1, a promising compound that is toxic to diverse tumor cell lines, is a saponin from Ornithogalum saundersia. In this study, we analyzed the stress responses induced by OSW-1 using the human colon cancer cell line HT-29 cells and compared it with the commonly used ER and Golgi stress inducers brefeldin A (BFA), thapsigargin (Tg), and tunicamycin (Tm). OSW-1 induced few ER stress-related factors, but there was an increase in expression of TFE3 protein, one of the Golgi stress response factors. A shift in the molecular weight of TFE3 was also found, likely attributable to dephosphorylation. Conversely, the impact of OSW-1 on the expression of the TFEB protein, another member of the MiTF/TFE family, was minimal. Cleavage of CREB3, another Golgi stress sensor, was apparently induced only by BFA. LC3-II and p62, autophagy-related factors, were increased in all drug treatments. Unexpectedly, OSBP protein levels, one of the targets of OSW-1, were increased by not only three reagents but also OSW-1. Taken together, OSW-1 treatment of HT-29 cells induced atypical Golgi stress that strongly activated the TFE3 pathway and did not involve the CREB3 pathway or the ER stress response. Although OSW-1 was also found to affect the autophagy system, it was suggested that the effects of OSW-1 may not be mediated by OSBP depletion. These findings will contribute to the development of OSW-1-based cancer therapies and to our understanding of Golgi stress responses.

Research topics

  • Phytochemical Studies and Bioactivities

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1248/bpbreports.8.1_1

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.